News | Coronavirus (COVID-19) | January 03, 2022

FDA Contraindicates Janssen COVID Vaccine for People With Previous Thrombosis With Thrombocytopenia 

FDA Contraindicates Janssen COVID Vaccine for People With Previous Thrombosis With Thrombocytopenia. #COVID19 #COVIDvaccine

January 3, 2022 — The U.S. Food and Drug Administration (FDA) recently revised its Janssen COVID-19 Vaccine Fact Sheets with a contraindication for any individuals with a history of thrombosis with thrombocytopenia following the Janssen COVID-19 vaccine or any other adenovirus-vectored COVID-19 vaccine.

The fact sheets now include updated information about the risk of thrombosis with thrombocytopenia syndrome (TTS) following vaccination. The updates Occurred December 14.

Cases of thrombosis with thrombocytopenia following administration of the Janssen COVID-19 vaccine have been reported in males and females 18 years of age and older. The highest reporting rate of approximately one case per 100,000 doses administered in females 30-49 years of age. Overall, the FDA said approximately 1 out of 7 cases has been fatal. 

The FDA and Centers for Disease Control and Prevention (CDC) said they continue to investigate the level of potential excess risk. The FDA said it continues to find that the known and potential benefits of the Janssen COVID-19 vaccine outweigh its known and potential risks in individuals 18 years of age and older. 

The FDA said individuals should speak to their healthcare provider to determine which COVID-19 vaccine is most appropriate for their own situation.

Access the Fact Sheet for Healthcare Providers Administering Vaccine

Access the Fact Sheet for Recipients and Caregivers

Find more COVID related cardiovascular content

 

Related Content

Feature | Coronavirus (COVID-19) | By Dave Fornell, DAIC Editor

By the end of the first year of the COVID-19 pandemic, there was a clear sign that some virus patients had longer ...

Home January 23, 2022
Home
Videos | Coronavirus (COVID-19)

Aaron Baggish, M.D., director of the cardiovascular performance program, Mass General Hospital, has been involved in the ...

Home January 20, 2022
Home
News | Coronavirus (COVID-19)

January 19, 2022 — Heart function recovery returned within three months in children who developed COVID-19 related multi ...

Home January 19, 2022
Home
News | Coronavirus (COVID-19)

January 4, 2022 — The Omicron variant, as of Dec. 25, made up 58.6% of new COVID-19 infections in the U.S., according to ...

Home January 04, 2022
Home
News | Coronavirus (COVID-19)

December 23, 2021 — An interdisciplinary research team from the University of Göttingen and Hannover Medical School (MHH ...

Home December 23, 2021
Home
Feature | Coronavirus (COVID-19)

COVID-19 was the single biggest topic readers came to DAIC for information in 2021, resulting in more than 300,000 ...

Home December 16, 2021
Home
News | Coronavirus (COVID-19)

December 15, 2021 — As COVID-19 variants continue to spread and individuals struggle with lingering effects long after ...

Home December 15, 2021
Home
Videos | Coronavirus (COVID-19)

Jean Jeudy, M.D., professor of radiology and vice chair of informatics at the University of Maryland School of Medicine ...

Home December 14, 2021
Home
News | Coronavirus (COVID-19)

December 7, 2021 – Critically ill patients with COVID-19 can safely be transported for lifesaving extracorporeal ...

Home December 07, 2021
Home
Videos | Coronavirus (COVID-19)

Kate Hanneman, M.D., MPH FRCPC, director of cardiac imaging research JDMI, and the medical imaging site director at ...

Home December 06, 2021
Home
Subscribe Now